Clinical Trial Update: Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating satraplatin in hormone-refractory (castration-resistant) prostate cancer patients who had previously received one cytotoxic chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• satraplatin (satraplatin)

Snippet

Sponsor: Agennix | Conditions: Prostate Cancer, Hormone Refractory Prostate Cancer | Phase 3 | Status: COMPLETED